University of Michigan School of Dentistry has signed an agreement with Interleukin Genetics Inc. to conduct what may be the largest clinical study to date using genetic testing to assess the risk for gum disease. William Giannobile, professor at U-M dentistry and director of the Michigan Center for Oral Health Research at the School of Dentistry, will lead the study for U-M. “It’s an exciting study because it’s a way to use genetic testing to personalize a dental treatment plan and the frequency of dental care visits of patients as it relates to oral care,” said Giannobile. “It’s a way to customize patient care.” “One of the goals of personalized health care is to detect disease earlier and prevent it more effectively,” said Kenneth Kornman, president and chief scientific officer of Waltham, Mass. based-Interleukin. The study will use Interleukin’s PST test as one part of a periodontitis risk assessment, said Kornman, who is also an alumnus of the U-M Dental School. Read full post…